ChemicalBook >> CAS DataBase List >>3H-Imidazo[4,5-b]pyridine-2-propanamide, N-[(1S)-1-(4-chlorophenyl)ethyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]-

3H-Imidazo[4,5-b]pyridine-2-propanamide, N-[(1S)-1-(4-chlorophenyl)ethyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]-

CAS No.
1979939-16-6
Chemical Name:
3H-Imidazo[4,5-b]pyridine-2-propanamide, N-[(1S)-1-(4-chlorophenyl)ethyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]-
Synonyms
CRT0273750;blood,ATX/LPA,4T1,Inhibitor,inhibit,clearance,CRT0273750,LPA;N-[1(S)-(4-Chlorophenyl)-ethyl]-3-[3-(4-trifluoromethoxybenzyl)-3H-imidazo[4,5-b]pyridin-2-yl]-propionamide;3H-Imidazo[4,5-b]pyridine-2-propanamide, N-[(1S)-1-(4-chlorophenyl)ethyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]-
CBNumber:
CB68596697
Molecular Formula:
C25H22ClF3N4O2
Molecular Weight:
502.92
MDL Number:
MFCD34567245
MOL File:
1979939-16-6.mol
Last updated:2023-04-23 13:52:06

3H-Imidazo[4,5-b]pyridine-2-propanamide, N-[(1S)-1-(4-chlorophenyl)ethyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]- Properties

Boiling point 680.4±55.0 °C(Predicted)
Density 1.35±0.1 g/cm3(Predicted)
solubility DMSO: Soluble
form A solid
pka 14.92±0.46(Predicted)

3H-Imidazo[4,5-b]pyridine-2-propanamide, N-[(1S)-1-(4-chlorophenyl)ethyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]- Chemical Properties,Uses,Production

Description

CRT0273750 is an autotaxin inhibitor. CRT0273750 modulates LPA levels in plasma and is suitable for in vivo studies. CRT0273750 has an unexpected binding mode in that they do not interact with the active site zinc ions but instead occupy the hydrophobic LPC pocket extending from the active site of ATX together with occupying the LPA 'exit' channel.

in vivo

The autotaxin-lysophosphatidic acid (ATX-LPA) axis has been implicated in several disease conditions including inflammation, fibrosis and cancer. This makes ATX an attractive drug target and its inhibition may lead to useful therapeutic agents. Through a high throughput screen (HTS), a series of small molecule inhibitors of ATX have been identified, which have subsequently been optimized for potency, selectivity and developability properties. This has delivered drug-like compounds such as 9v (CRT0273750) which modulate LPA levels in plasma and are suitable for in vivo studies. X-ray crystallography has revealed that these compounds have an unexpected binding mode in that they do not interact with the active site zinc ions but instead occupy the hydrophobic LPC pocket extending from the active site of ATX together with occupying the LPA 'exit' channel._x000D_ _x000D_ Reference: Shah P, Cheasty A, Foxton C, Raynham T, Farooq M, Gutierrez IF, Lejeune A, Pritchard M, Turnbull A, Pang L, Owen P, Boyd S, Stowell A, Jordan A, Hamilton NM, Hitchin JR, Stockley M, MacDonald E, Quesada MJ, Trivier E, Skeete J, Ovaa H, Moolenaar WH, Ryder H. Discovery of potent inhibitors of the lysophospholipase autotaxin. Bioorg Med Chem Lett. 2016 Nov 15;26(22):5403-5410. doi: 10.1016/j.bmcl.2016.10.036. Epub 2016 Oct 14. PMID: 27780639.

target

Novel potent inhibitor of the lysophospholipase autotaxin

3H-Imidazo[4,5-b]pyridine-2-propanamide, N-[(1S)-1-(4-chlorophenyl)ethyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]- Preparation Products And Raw materials

Raw materials

Preparation Products

3H-Imidazo[4,5-b]pyridine-2-propanamide, N-[(1S)-1-(4-chlorophenyl)ethyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]- Suppliers

Global( 11)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
Aladdin Scientific
+1-+1(833)-552-7181 sales@aladdinsci.com United States 52927 58
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. 17702719238 17702719238 sales@sun-shinechem.com China 918 64
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9708 58
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994 2853530910@QQ.com China 8011 62
Wuhan Sun-shine Bio-technology Corporation Limited +86-027-6552-2453 sales@sun-shinechem.com China 727 58
Changzhou Furuisi Biotechnology Co., Ltd 0519-85524369 3477467573@qq.com China 8618 58
TargetMol Chemicals Inc. 4008200310 marketing@tsbiochem.com China 24017 58
Shanghai jerryxing Biomedical Technology Co., Ltd 17721492509 643638326@qq.com China 5347 58
Nanjing Shizhou Biology Technology Co.,Ltd 025-85560043 15850508050 cindy.huang@synzest.com China 12007 58
3H-Imidazo[4,5-b]pyridine-2-propanamide, N-[(1S)-1-(4-chlorophenyl)ethyl]-3-[[4-(trifluoromethoxy)phenyl]methyl]- CRT0273750 blood,ATX/LPA,4T1,Inhibitor,inhibit,clearance,CRT0273750,LPA N-[1(S)-(4-Chlorophenyl)-ethyl]-3-[3-(4-trifluoromethoxybenzyl)-3H-imidazo[4,5-b]pyridin-2-yl]-propionamide 1979939-16-6 C25H22ClF3N4O2